Day 2 of South by Southwest delved into the ways creative people deal with fast-changing technology. Here's the latest from Austin.
Recently, a pharmaceutical company came to the antibody-discovery specialist, Abveris, with a serious problem. The pharmaceutical company had tried and failed to develop a monoclonal antibody for an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results